AI

Annat Ikin

Director, Medical Writing at Geron

Annat Ikin has a solid work history in the field of medical writing. Annat is currently employed as the Director of Medical Writing at Geron Corporation since November 2021. Prior to that, they worked at Celgene for over 14 years, starting as a Senior Medical Writer from January 2007 to October 2009, and later as a Principal Medical Writer from November 2009 to October 2021. Before joining Celgene, they worked as a Research Assistant Professor at Thomas Jefferson University from August 2004 to January 2007. Annat started their career as an Instructor at the Mount Sinai School of Medicine from April 2000 to July 2004 and previously served as a Postdoctoral Fellow at Rockefeller University from January 1994 to March 2000.

Annat Ikin received a PhD in Biochemistry from Tel Aviv University, completing their studies from 1988 to 1993.

Location

Summit, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Geron

4 followers

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.